🇺🇸 LGND — Ligand Pharmaceuticals Incorporated
Salud Compra fuertePrecio actual
306,20 USD
Máx. histórico
322,75
7 días
Split 1603:1000 del 02/11/2022
Caída desde máximo
-5,13%
Rango 52 semanas
175,89 – 326,63
Variación hoy
+2,41%
Cierre anterior
299,00
Rango de hoy
297,84 – 308,26
Volumen hoy
130.173
Peor caída histórica
-93,34%
06/03/2000 → 19/11/2008
Recuperado en 2694 días
Volatilidad anualizada ⓘ
59,76%
- Nombre completo
- Ligand Pharmaceuticals Incorporated
- Divisa
- USD
- Mercado
- NasdaqGM
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 47
- PER ⓘ
- 122,97 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 351,33 USD (puede no estar actualizado)
- Primera cotización
- 18/11/1992
- Precio actualizado
- hace 19 horas
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.
| Fecha de pago | Importe por participación |
|---|---|
| 03/04/2007 | 9,3575 USD |
| Fecha | Ratio |
|---|---|
| 02/11/2022 | 1603:1000 |
| 19/11/2010 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 24/08/2012 | 10,12 | 10,36 | 10,12 | 10,20 | +0,37% | 2,34% | 50.975 |
| 23/08/2012 | 10,14 | 10,22 | 10,06 | 10,16 | -0,18% | 1,54% | 57.708 |
| 22/08/2012 | 9,99 | 10,27 | 9,99 | 10,18 | +0,18% | 2,75% | 106.600 |
| 21/08/2012 | 10,31 | 10,54 | 10,04 | 10,16 | -1,27% | 4,90% | 127.599 |
| 20/08/2012 | 10,25 | 10,34 | 10,06 | 10,29 | +0,00% | 2,74% | 130.164 |
| 17/08/2012 | 10,30 | 10,34 | 10,02 | 10,29 | +0,12% | 3,09% | 107.401 |
| 16/08/2012 | 10,34 | 10,34 | 10,01 | 10,28 | -0,54% | 3,20% | 131.767 |
| 15/08/2012 | 10,02 | 10,44 | 9,99 | 10,34 | +3,95% | 4,55% | 133.370 |
| 14/08/2012 | 10,24 | 10,27 | 9,86 | 9,94 | -2,80% | 4,02% | 201.177 |
| 13/08/2012 | 10,22 | 10,25 | 10,15 | 10,23 | -0,67% | 0,98% | 138.660 |
| 10/08/2012 | 10,47 | 10,56 | 10,27 | 10,30 | -2,71% | 2,74% | 161.422 |
| 09/08/2012 | 11,24 | 11,25 | 9,99 | 10,59 | -6,35% | 11,15% | 895.756 |
| 08/08/2012 | 11,58 | 11,75 | 11,23 | 11,30 | -2,58% | 4,53% | 146.835 |
| 07/08/2012 | 11,82 | 11,95 | 11,59 | 11,60 | -1,54% | 3,06% | 116.538 |
| 06/08/2012 | 12,02 | 12,15 | 11,75 | 11,78 | -1,51% | 3,27% | 122.950 |
| 03/08/2012 | 11,87 | 12,08 | 11,66 | 11,97 | +2,18% | 3,52% | 221.214 |
| 02/08/2012 | 11,81 | 11,85 | 11,43 | 11,71 | -1,88% | 3,59% | 277.800 |
| 01/08/2012 | 12,11 | 12,16 | 11,86 | 11,93 | -1,14% | 2,52% | 293.509 |
| 31/07/2012 | 12,04 | 12,14 | 11,95 | 12,07 | +0,36% | 1,55% | 264.014 |
| 30/07/2012 | 12,08 | 12,38 | 11,92 | 12,03 | +0,16% | 3,87% | 199.253 |
| 27/07/2012 | 11,45 | 12,18 | 11,35 | 12,01 | +5,19% | 7,24% | 376.705 |
| 26/07/2012 | 11,29 | 11,45 | 11,29 | 11,42 | +2,23% | 1,44% | 144.270 |
| 25/07/2012 | 11,23 | 11,29 | 11,05 | 11,17 | +1,65% | 2,17% | 221.855 |
| 24/07/2012 | 11,22 | 11,22 | 10,94 | 10,99 | -2,22% | 2,56% | 106.760 |
| 23/07/2012 | 10,39 | 11,29 | 10,39 | 11,24 | +2,86% | 8,64% | 389.529 |
| 20/07/2012 | 10,85 | 11,29 | 10,51 | 10,92 | -0,11% | 7,25% | 972.380 |
| 19/07/2012 | 10,71 | 11,00 | 10,64 | 10,94 | +2,10% | 3,44% | 146.835 |
| 18/07/2012 | 10,74 | 10,99 | 10,64 | 10,71 | -0,58% | 3,31% | 122.790 |
| 17/07/2012 | 11,02 | 11,04 | 10,74 | 10,77 | -1,82% | 2,72% | 148.758 |
| 16/07/2012 | 11,17 | 11,17 | 10,89 | 10,97 | -2,11% | 2,51% | 96.180 |